Placental infarction and thrombophilia

Obstetrics and Gynecology

Volumn 117, Issue 4, 2011, Pages 929-934

  Franco, Christopher ^a,b,c   Walker, Melissa ^a,b,c   Robertson, Julie ^a,b,c   Fitzgerald, Brendan ^a,b,c   Keating, Sarah ^a,b,c   McLeod, Anne ^a,b,c   Kingdom, John C P ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HUMAN; INFARCTION; MAJOR CLINICAL STUDY; PLACENTA DEVELOPMENT; PLACENTA DISORDER; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOPHILIA;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; INFARCTION; MATERNAL AGE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; THROMBOPHILIA; YOUNG ADULT;

EID: 79953183661     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31820ca040     Document Type: Article

References (27)

1. Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 2003;189:1173-7. (Pubitemid 37373917)
2. Ferrazzi E, Bulfamante G, Mezzopane R, Barbera A, Ghidini A, Pardi G. Uterine Doppler velocimetry and placental hypoxic- ischemic lesion in pregnancies with fetal intrauterine growth restriction. Placenta 1999;20:389-94. (Pubitemid 29301611)
3. Toal M, Keating S, Machin G, Dodd J, Adamson SL, Windrim RC, et al. Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images. Am J Obstet Gynecol 2008;198:330 1-7.
4. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13. (Pubitemid 29024678)
5. Rodger MA, Betancourt MT, Clark P, Lindqvist PG, Dizon- Townson D, Said J, et al. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies. PLoS Med 2010;7:e1000292.
6. Proctor LK, Toal M, Keating S, Chitayat D, Okun N, Windrim RC, et al. Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancyassociated plasma protein-A. Ultrasound Obstet Gynecol 2009; 34:274-82.
7. Dugoff L. First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes. Obstet Gynecol 2010;115:1052-61.
8. Toal M, Chan C, Fallah S, Alkazaleh F, Chaddha V, Windrim RC, et al. Usefulness of a placental profile in high-risk pregnancies. Am J Obstet Gynecol 2007;196:363 e1-7.
9. Viero S, Chaddha V, Alkazaleh F, Simchen MJ, Malik A, Kelly E, et al. Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries. Placenta 2004;25:735-41. (Pubitemid 39185951)
10. Kramer MS, Platt RW, Wen SW, Joseph KS, Allen A, Abrahamowicz M, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001;108:E35.
11. Diagnosis and management of preeclampsia and eclampsia. Practice Bulletin No. 33. American College of Obstetricians and Gynecologists Obstet Gynecol 2002;99:159-67.
12. Kraus FT, Redline RW, Gersell DJ, Nelson DM, Dicke JM. Placental pathology. Washington (DC): American Registry of Pathology; 2004.
13. Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 2003;162:115-25. (Pubitemid 36041994)
14. Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009;30:473-82.
15. Iwata M, Matsuzaki N, Shimizu I, Mitsuda N, Nakayama M, Suehara N. Prenatal detection of ischemic changes in the placenta of the growth-retarded fetus by Doppler flow velocimetry of the maternal uterine artery. Obstet Gynecol 1993; 82(4 Pt 1):494-9. (Pubitemid 23278245)
16. Sood R, Kalloway S, Mast AE, Hillard CJ, Weiler H. Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. Blood 2006;107:3173-80.
17. Baczyk D, Drewlo S, Proctor L, Dunk C, Lye S, Kingdom J. Glial cell missing-1 transcription factor is required for the differentiation of the human trophoblast. Cell Death Differ 2009;16:719-27.
18. Chen CP, Chen CY, Yang YC, Su TH, Chen H. Decreased placental GCM1 (glial cells missing) gene expression in preeclampsia. Placenta 2004;25:413-21. (Pubitemid 38519115)
19. Krebs C, Macara LM, Leiser R, Bowman AW, Greer IA, Kingdom JC. Intrauterine growth restriction with absent enddiastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol 1996;175:1534-42. (Pubitemid 27021025)
20. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998;281:1191-3. (Pubitemid 28406294)
21. Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W, et al. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 2001;81:1143-52. (Pubitemid 32772074)
22. Kaandorp SP, Goddijn M, van der Post JA, Hutten BA, Verhoeve HR, Hamulyak K, et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010;362:1586-96.
23. Gris JC, Mercier E, Quere I, Lavigne-Lissalde G, Cochery- Nouvellon E, Hoffet M, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004;103:3695-9. (Pubitemid 38596284)
24. Rey E, Garneau P, David M, Gauthier R, Leduc L, Michon N, et al. Dalteparin for the prevention of recurrence of placentalmediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost 2009;7:58-64.
25. Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol 2009;36: 279-87.
26. Clark P, Walker ID, Langhorne P, Crichton L, Thomson A, Greaves M, et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of lowmolecular- weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 2010;115:4162-7.
27. Drewlo S, Walker M, Mcleod A, Dodd J, Kingdom J. Heparin in human placental development and the prevention of placental complications of pregnancy. Fetal Matern Med Rev 2010;21:185-203.